Qingfei Chu

2.5k total citations · 5 hit papers
30 papers, 1.5k citations indexed

About

Qingfei Chu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Qingfei Chu has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Qingfei Chu's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers) and Liver Disease Diagnosis and Treatment (5 papers). Qingfei Chu is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers) and Liver Disease Diagnosis and Treatment (5 papers). Qingfei Chu collaborates with scholars based in China, United States and Ethiopia. Qingfei Chu's co-authors include Xinyu Gu, Lanjuan Li, Qiuxian Zheng, Zhengyi Bao, Qingmiao Shi, Yuanshuai Su, Juan Lu, Haihong Zhu, Xue Chen and Ganglei Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Metabolism and Scientific Reports.

In The Last Decade

Qingfei Chu

28 papers receiving 1.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tryptophan metabolism in health and disease

2023 467 citations Xue Chen, Qiuxian Zheng et al. profile →
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

2023 310 citations Xue Chen, Qinfan Yao et al. Signal Transduction and Targeted Therapy profile →
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies

2024 149 citations Qingmiao Shi, Chen Xue et al. Signal Transduction and Targeted Therapy profile →
Current understanding of the intratumoral microbiome in various tumors

2023 90 citations Xue Chen, Qingfei Chu et al. profile →
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances

2025 39 citations Xue Chen, Qingfei Chu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingfei Chu China	15	856	350	274	226	144	30	1.5k
Qingmiao Shi China	15	758 0.9×	249 0.7×	241 0.9×	186 0.8×	144 1.0×	35	1.4k
Xiuting Liu China	22	1.0k 1.2×	282 0.8×	488 1.8×	663 2.9×	86 0.6×	46	1.9k
Lingling Liu China	24	1.1k 1.3×	376 1.1×	202 0.7×	332 1.5×	40 0.3×	105	2.0k
Mourad Zerfaoui United States	22	633 0.7×	181 0.5×	469 1.7×	388 1.7×	74 0.5×	49	1.5k
Weiwei Pan China	18	1.3k 1.5×	373 1.1×	447 1.6×	275 1.2×	56 0.4×	38	2.2k
Dae Young Hur South Korea	26	830 1.0×	231 0.7×	453 1.7×	611 2.7×	73 0.5×	102	1.8k
Linda Zhang United States	24	1.7k 2.0×	620 1.8×	207 0.8×	148 0.7×	70 0.5×	63	2.3k
Qiang Guo China	21	888 1.0×	335 1.0×	207 0.8×	686 3.0×	49 0.3×	54	1.8k
Liwei Liu China	20	500 0.6×	268 0.8×	105 0.4×	106 0.5×	97 0.7×	79	1.2k

Countries citing papers authored by Qingfei Chu

Since Specialization

Citations

This map shows the geographic impact of Qingfei Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfei Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfei Chu more than expected).

Fields of papers citing papers by Qingfei Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfei Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfei Chu. The network helps show where Qingfei Chu may publish in the future.

Co-authorship network of co-authors of Qingfei Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfei Chu. A scholar is included among the top collaborators of Qingfei Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfei Chu. Qingfei Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xue, Qingfei Chu, Qingmiao Shi, et al.. (2025). Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Signal Transduction and Targeted Therapy. 10(1). 106–106. 39 indexed citations breakdown →

Rashid, Abdur, Kang Li, Yi Feng, et al.. (2024). Identification of a novel first-generation HIV-1 circulating recombinant form (CRF152_DG) among people living with HIV in Karachi, Pakistan. Microbiology Spectrum. 12(7). e0052924–e0052924.

Chen, Huanhuan, Jianjun Li, Yi Feng, et al.. (2024). Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4 ⁺ T-cell loss. mBio. 15(3). e0334923–e0334923. 1 indexed citations

Rashid, Abdur, Kang Li, Yi Feng, et al.. (2024). Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan. Viruses. 16(6). 962–962. 1 indexed citations

Shi, Qingmiao, Chen Xue, Yifan Zeng, et al.. (2024). Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduction and Targeted Therapy. 9(1). 128–128. 149 indexed citations breakdown →

Shi, Qingmiao, Yifan Zeng, Xue Chen, et al.. (2024). Development of a promising PPAR signaling pathway-related prognostic prediction model for hepatocellular carcinoma. Scientific Reports. 14(1). 4926–4926. 11 indexed citations

Shi, Qingmiao, Shuwen Jiang, Yifan Zeng, et al.. (2024). A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. Journal of Translational Internal Medicine. 12(6). 553–568. 2 indexed citations

Jia, Junjun, Xuelian Zhou, & Qingfei Chu. (2024). Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer. Molecular and Cellular Biochemistry. 480(1). 1–17. 13 indexed citations

Shi, Qingmiao, Xue Chen, Yifan Zeng, et al.. (2024). PPARα agonist ameliorates cholestatic liver injury by regulating hepatic macrophage homeostasis. International Journal of Biological Macromolecules. 287. 138510–138510.

10.

Chen, Xue, Qinfan Yao, Xinyu Gu, et al.. (2023). Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduction and Targeted Therapy. 8(1). 204–204. 310 indexed citations breakdown →

11.

Xue, Chen, Xinyu Gu, Qiuxian Zheng, et al.. (2023). Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis. Advanced Science. 10(16). e2207074–e2207074. 26 indexed citations

12.

Shi, Qingmiao, Qingfei Chu, Yifan Zeng, et al.. (2023). Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications. Cell Communication and Signaling. 21(1). 359–359. 11 indexed citations

13.

Chu, Qingfei, Xinyu Gu, Qiuxian Zheng, Jing Wang, & Haihong Zhu. (2022). Phosphoribosyl Pyrophosphate Amido Transferase: A New Prognostic Biomarker for Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations

14.

Zheng, Qiuxian, Xinyu Gu, Dandan Shan, et al.. (2022). Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development. Frontiers in Cell and Developmental Biology. 10. 830702–830702. 3 indexed citations

15.

Xue, Chen, Qingfei Chu, Qiuxian Zheng, et al.. (2022). Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduction and Targeted Therapy. 7(1). 142–142. 133 indexed citations

16.

Zheng, Qiuxian, et al.. (2021). The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. DNA and Cell Biology. 40(7). 848–857. 10 indexed citations

17.

Chu, Qingfei, Xinyu Gu, Qiuxian Zheng, et al.. (2021). Long noncoding RNA SNHG4: a novel target in human diseases. Cancer Cell International. 21(1). 583–583. 28 indexed citations

18.

Gu, Xinyu, Qiuxian Zheng, Qingfei Chu, & Haihong Zhu. (2021). HAND2-AS1: A functional cancer-related long non-coding RNA. Biomedicine & Pharmacotherapy. 137. 111317–111317. 27 indexed citations

19.

Gu, Xinyu, Qingfei Chu, Qiuxian Zheng, Jing Wang, & Haihong Zhu. (2021). The dual functions of the long noncoding RNA CASC15 in malignancy. Biomedicine & Pharmacotherapy. 135. 111212–111212. 18 indexed citations

20.

Chu, Qingfei, Xinyu Gu, Qiuxian Zheng, & Haihong Zhu. (2021). Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review. Annals of Translational Medicine. 10(2). 109–109. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact